clarithromycin has been researched along with Erythema Multiforme in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Asahina, A; Kikuchi, S; Nobeyama, Y; Saeki, H | 1 |
| Brito, C; Santos, RP; Silva, M; Vieira, AP | 1 |
| Horio, A; Kamiya, K; Nishio, E; Tokura, Y | 1 |
3 other study(ies) available for clarithromycin and Erythema Multiforme
| Article | Year |
|---|---|
Characteristics of cutaneous adverse drug reactions caused by triple-combination drug therapy used for Helicobacter pylori eradication.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sex Factors; Stevens-Johnson Syndrome; Sulfonamides | 2020 |
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Diagnosis, Differential; Erythema Multiforme; Fever; Humans; Immunoglobulins, Intravenous; Male; Mucositis; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Tomography, X-Ray Computed | 2017 |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Erythema Multiforme; Female; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2016 |